Provided by Tiger Fintech (Singapore) Pte. Ltd.

Spero Therapeutics Inc.

2.80
-0.0500-1.75%
Post-market: 2.800.00000.00%18:52 EDT
Volume:1.89M
Turnover:5.26M
Market Cap:156.55M
PE:-2.19
High:2.89
Open:2.85
Low:2.64
Close:2.85
Loading ...
Mar 20, 2024

Correspondence

Form CORRESP - Correspondence
Mar 15, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 13, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Jan 02, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Oct 17, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 11, 2023

Major Issues Report

Form 8-K - Current report